Related Experiment Video
Updated: Mar 15, 2026

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice
Published on: April 16, 2018
Melatonin as a Redox Modulator in Developmental Programming: Implications for Cardiovascular-Kidney-Metabolic Risk
Chien-Ning Hsu1,2,3, You-Lin Tain4,5,6
1Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung 801, Taiwan.
Maternal melatonin supplementation shows promise in preventing fetal programming of cardiovascular, kidney, and metabolic disorders by combating oxidative stress. Further research is needed to establish optimal dosing and long-term safety for offspring.
Area of Science:
- Reproductive biology and developmental toxicology
- Endocrinology and metabolic research
- Perinatal medicine
Background:
- Melatonin is crucial for healthy pregnancy and fetal development, exhibiting antioxidant, anti-inflammatory, and chronobiotic properties.
- Excessive oxidative stress during development can lead to maladaptive fetal programming, increasing lifelong risks for cardiovascular, kidney, and metabolic (CKM) disorders.
- Current evidence on maternal melatonin's protective effects is largely from rodent models and shows variable results.
Purpose of the Study:
- To review mechanistic and translational evidence on melatonin's role in mitigating intergenerational risks of CKM disorders.
- To explore melatonin's potential as a preventive strategy against adverse fetal programming.
- To synthesize findings on melatonin's impact on redox homeostasis, epigenetic pathways, and the gut microbiome.
Main Methods:
- Synthesis of mechanistic studies from experimental models.
- Review of early clinical investigations in human pregnancies.
- Analysis of melatonin's effects on oxidative stress, epigenetic modifications, nutrient sensing, and gut microbiota.
Main Results:
- Experimental studies suggest maternal melatonin can prevent programmed hypertension, renal dysfunction, and metabolic issues by restoring redox balance.
- Melatonin influences epigenetic and nutrient-sensing pathways and modulates the gut microbiome.
- Initial clinical studies indicate melatonin is well-tolerated in pregnancies with preeclampsia or intrauterine growth restriction, improving placental function and neonatal outcomes.
Conclusions:
- Maternal melatonin supplementation shows potential in preventing programmed CKM disorders by addressing oxidative stress and related pathways.
- Clinical investigations suggest benefits for placental function and neonatal outcomes, though optimal dosing and long-term safety require further study.
- Melatonin emerges as a potential integrative mediator for preventive strategies against the intergenerational transmission of CKM syndrome.
More Related Videos
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
10:00Induction and Analysis of Oxidative Stress in Sleeping Beauty Transposon-Transfected Human Retinal Pigment Epithelial Cells
Published on: December 11, 2020
Related Concept Videos
Circadian Rhythms and Gene Regulation
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Redox Reactions
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Management of Insomnia